Red Tortoise’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
Other funds holding KROS
Red Tortoise's KROS Position: Q1 2026 in Review
Red Tortoise held its Keros Therapeutics (KROS) position steady in Q1 2026 at 56 shares worth $618. The position accounts for ﹤0.01% of the portfolio, ranked #579.
Red Tortoise first reported a position in KROS in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.31K in Q3 2025. 151 funds tracked by Wall St. Rank hold KROS as of Q1 2026.
- Red Tortoise held 56 shares of Keros Therapeutics worth $618 as of Q1 2026.
- Red Tortoise left its Keros Therapeutics share count unchanged in Q1 2026.
- Keros Therapeutics made up ﹤0.01% of Red Tortoise's portfolio in Q1 2026, its #579 holding.
- Red Tortoise first reported a position in Keros Therapeutics in Q2 2025 and has held it in 4 quarters since.
- Red Tortoise's Keros Therapeutics position peaked at $2.31K in Q3 2025.
- 151 funds tracked by Wall St. Rank held Keros Therapeutics as of Q1 2026.
Based on Red Tortoise's 13F filing for Q1 2026, filed 21 Apr 2026.